NCT Number: NCT00177125
Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP
The purpose of this study is to perform a randomized prospective study to evaluate whether the vacuum erection device facilitates an earlier return of erectile function post radical prostatectomy. A secondary measure will be to evaluate if the vacuum erection device can help prevent penile shortening.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
Male
Study type
Interventional
Phase
Phase 3
Primary location
University of Minnesota, Minneapolis, Minnesota, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients undergoing a radical prostatectomy for prostate cancer who are able to attain a partial or full erection preoperatively and are sexually active.
Exclusion criteria
- Patients on anticoagulation therapy and those with bleeding diatheses
- Insufficient manual dexterity of patient or spouse
- IIEF(International Index of Erectile Function) at baseline < 11, indicating severe erectile dysfunction
Treatment and study plan
Sponsors and collaborators
Lead sponsor
University of Minnesota
Other
Collaborators
- Endocare, Inc.
- Manoj, Monga, M.D.
Registry information
Official study title
Evaluating the Effect of the Vacuum Constriction Device on Erectile Function and Penile Length Post Radical Retropubic Prostatectomy
Important dates
- Study start
- 2004
- Primary completion
- 2004
- Study completion
- 2004
- First posted
- Sep 15, 2005
- Registry last updated
- Feb 6, 2012
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)
NCT04108208
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsStudy of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
NCT03834493
Genital Diseases, Genital Diseases, Male
Mobile, Alabama, United States
View Trial DetailsImpact on Quality of Life 3 Years After Diagnosis of Prostate Cancer
NCT02854982
Genital Diseases, Genital Diseases, Male
Nîmes, Gard, France
View Trial DetailsGenetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution
NCT03421015
Disease Attributes, Genital Diseases
Lille, France
View Trial Details